Publications by authors named "J Courjon"

Claim this Profile
E
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trial.
Clément R Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard, Simon Jamard, François Goehringer, Johan Courjon

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ruxolitinib, disseminated tuberculosis and primary myelofibrosis: A case study].
A Gérard, V Cauhape, J Courjon, D Viard, L Inchiappa

Rev Mal Respir· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial.
David M Smadja, Clément R Massonnaud, Aurélien Philippe, Mickael Rosa, Sophie Luneau, Johan Courjon

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Cefiderocol Use in Bone and Joint Infection: A French National Cohort.
Ava Diarra, Maxime Degrendel, Isabelle Eberl, Tristan Ferry, Karim Jaffal, Johan Courjon

Antibiotics (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-articular procedures and associated septic arthritis: A mini-review.
François Vidal, Michel Carles, Johan Courjon

Infect Dis Now· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis